These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30411268)

  • 21. ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?
    Morrison S; Zager JS; Vetto J
    Ann Surg Oncol; 2022 May; 29(5):2867-2868. PubMed ID: 35059884
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolated limb infusion: a review.
    Kroon HM; Thompson JF
    J Surg Oncol; 2009 Aug; 100(2):169-77. PubMed ID: 19365813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASO Author Reflections: Adjuvant Treatment of Melanoma in the Modern Era.
    Rauwerdink DJW; Boland GM
    Ann Surg Oncol; 2020 Dec; 27(13):5137-5138. PubMed ID: 32468350
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: Staging System for Mucosal Melanoma: A Proposal to Fill a Gap.
    Cui C; Lian B; Guo J
    Ann Surg Oncol; 2022 Aug; 29(8):5235-5236. PubMed ID: 35412206
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
    Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
    Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: Why Treatment Risk Thresholds Are Needed for Patients with Melanoma.
    Bartlett EK; Marchetti MA
    Ann Surg Oncol; 2022 Sep; 29(9):5957-5958. PubMed ID: 35524083
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.
    Bartlett DL; Ma G; Alexander HR; Libutti SK; Fraker DL
    Cancer; 1997 Dec; 80(11):2084-90. PubMed ID: 9392330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis.
    Ma Q; Zhao Z; Barber BL; Shilkrut M
    Adv Ther; 2016 Feb; 33(2):282-9. PubMed ID: 26797898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASO Author Reflections: Gene Expression Profiling for Melanoma: Is it Ready for Prime Time?
    Kangas-Dick A; Berger AC; Koshenkov V
    Ann Surg Oncol; 2021 Aug; 28(8):4590-4591. PubMed ID: 33479864
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Extracapsular Spread in Melanoma Lymphadenopathy: Prognostic Implications, Classification, and Management.
    Lo M; Peach H; Moncrieff M
    Ann Surg Oncol; 2021 Mar; 28(3):1654-1655. PubMed ID: 33083908
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
    Testori A; Verhoef C; Kroon HM; Pennacchioli E; Faries MB; Eggermont AM; Thompson JF
    J Surg Oncol; 2011 Sep; 104(4):397-404. PubMed ID: 21858835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO Author Reflections: Should We Be Using Dextrose-Containing Carrier Solutions for Perfusion During HIPEC?
    Stewart CL; McCarter M
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):834-835. PubMed ID: 30276640
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical management and current research in isolated limb perfusion for sarcoma and melanoma.
    Hohenberger P; Kettelhack C
    Oncology; 1998; 55(2):89-102. PubMed ID: 9499194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaesthetic experience with isolated limb perfusion with melphalan for melanoma.
    Kam PC; Thompson JF
    Perfusion; 1996 Sep; 11(5):395-9. PubMed ID: 8888062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges.
    Chakera AH; Thompson JF
    Ann Surg Oncol; 2019 Apr; 26(4):1044-1045. PubMed ID: 30719637
    [No Abstract]   [Full Text] [Related]  

  • 37. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma.
    Tominaga R; Kohno H; Mayumi H; Shiraishi K; Nagae S; Nakayama J; Yasui H
    Surg Today; 2000; 30(4):339-42. PubMed ID: 10795866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
    Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
    Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.